On this news, HealthEquity's shares fell 17% on March 19, 2025.

HealthEquity HQY has faced a challenging start to 2025, with the stock plunging more than 13.1% year to date compared with the industry’s 1.5% and S&P 500 Index’s 9.2% decline, respectively. This ...

New claims technology recognized for both automation and health AI from the Business Intelligence GroupDRAPER, Utah, April 15, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY ...

NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HealthEquity, Inc (“HealthEquity” or the “Company”) (NASDAQ: HQY).

KeyBanc lowered the firm’s price target on HealthEquity (HQY) to $100 from $110 and keeps an Overweight rating on the shares. Into Q1 earnings, the firm believes the focus for the HCIT sector will be ...

It has been about a month since the last earnings report for HealthEquity (HQY). Shares have lost about 2.2% in that time frame, outperforming the S&P 500. Will the recent negative trend continue ...

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of HealthEquity, Inc. (NASDAQ: HQY) resulting from ...

Read Our Latest Research Report on HealthEquity HealthEquity Trading Up 2.8 % NASDAQ HQY opened at $82.20 on Friday. The stock has a market cap of $7.11 billion, a PE ratio of 75.41, a PEG ratio ...

HealthEquity stock opened at $88.83 on Thursday. HealthEquity has a 52-week low of $65.01 and a 52-week high of $115.59. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt ...

HealthEquity, Inc. (NASDAQ:HQY), a leading provider of health savings accounts (HSAs) and related services in the United States, has been navigating a complex landscape of growth opportunities and ...

HealthEquity HQY has faced a challenging start to 2025, with the stock plunging more than 13.1% year to date compared with the industry’s 1.5% and S&P 500 Index’s 9.2% decline, respectively.

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of HealthEquity, Inc. (NASDAQ ...